These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 2254323

  • 1. Bifunctional thrombin inhibitors based on the sequence of hirudin45-65.
    DiMaio J, Gibbs B, Munn D, Lefebvre J, Ni F, Konishi Y.
    J Biol Chem; 1990 Dec 15; 265(35):21698-703. PubMed ID: 2254323
    [Abstract] [Full Text] [Related]

  • 2. A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bond.
    DiMaio J, Ni F, Gibbs B, Konishi Y.
    FEBS Lett; 1991 Apr 22; 282(1):47-52. PubMed ID: 2026264
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antithrombin properties of C-terminus of hirudin using synthetic unsulfated N alpha-acetyl-hirudin45-65.
    Krstenansky JL, Mao SJ.
    FEBS Lett; 1987 Jan 19; 211(1):10-6. PubMed ID: 3803584
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thrombin-specific inhibition by and slow cleavage of hirulog-1.
    Witting JI, Bourdon P, Brezniak DV, Maraganore JM, Fenton JW.
    Biochem J; 1992 May 01; 283 ( Pt 3)(Pt 3):737-43. PubMed ID: 1290488
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The C-terminal binding domain of hirullin P18. Antithrombin activity and comparison to hirudin peptides.
    Krstenansky JL, Owen TJ, Yates MT, Mao SJ.
    FEBS Lett; 1990 Sep 03; 269(2):425-9. PubMed ID: 2401369
    [Abstract] [Full Text] [Related]

  • 11. Anticoagulant activity of synthetic hirudin peptides.
    Maraganore JM, Chao B, Joseph ML, Jablonski J, Ramachandran KL.
    J Biol Chem; 1989 May 25; 264(15):8692-8. PubMed ID: 2722794
    [Abstract] [Full Text] [Related]

  • 12. Conformationally restricted thrombin inhibitors resistant to proteolytic digestion.
    Szewczuk Z, Gibbs BF, Yue SY, Purisima EO, Konishi Y.
    Biochemistry; 1992 Sep 29; 31(38):9132-40. PubMed ID: 1390700
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.
    Kelly AB, Maraganore JM, Bourdon P, Hanson SR, Harker LA.
    Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):6040-4. PubMed ID: 1385867
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The fibrinogen anion-binding exosite of thrombin is necessary for induction of rises in intracellular calcium and prostacyclin production in endothelial cells.
    Ngaiza JR, Manley G, Grulich-Henn J, Krstenansky JL, Jaffe EA.
    J Cell Physiol; 1992 Apr 01; 151(1):190-6. PubMed ID: 1560043
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hirulog peptides with scissile bond replacements resistant to thrombin cleavage.
    Kline T, Hammond C, Bourdon P, Maraganore JM.
    Biochem Biophys Res Commun; 1991 Jun 28; 177(3):1049-55. PubMed ID: 2059196
    [Abstract] [Full Text] [Related]

  • 19. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH, Sze P, Winant RC, Hudson D, Underhill P, Lazar JB, Olsen C, Almquist R.
    Haemostasis; 1991 Jun 28; 21 Suppl 1():41-8. PubMed ID: 1894196
    [Abstract] [Full Text] [Related]

  • 20. Distinct binding sites of Ala48-hirudin1-47 and Ala48-hirudin48-65 on alpha-thrombin.
    Dodt J, Köhler S, Schmitz T, Wilhelm B.
    J Biol Chem; 1990 Jan 15; 265(2):713-8. PubMed ID: 2295615
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.